Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Posteriorchamber Intraocular Lens

Research Leaders

7 sponsors active, led by MaganaMed GmbH

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Posteriorchamber Intraocular Lens1
  • Odyssey Iol1
  • At Elana1

Active Sponsors

  • MaganaMed GmbH1
  • Prim. Prof. Dr. Oliver Findl, MBA1
  • Sengi1
  • Carl Zeiss Meditec AG1
  • European Society of Cataract and Refractive Surgeons1

Top Investigators

Related Conditions

  • Cataract3
  • Aphakia1
  • Clear Lens Exchange1
  • Myopia1
  • Pseudophakic Retinal Detachment1

Activity Timeline